AAAAAA
Results:
1-14
|
Results: 14
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
VonHoff, DD
Kaye, SB
Citation: I. Ganly et al., A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 7(3), 2001, pp. 754-754
Authors:
Mulvihlll, S
Warren, R
Venook, A
Adler, A
Randlev, B
Heise, C
Kirn, D
Citation: S. Mulvihlll et al., Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial, GENE THER, 8(4), 2001, pp. 308-315
Authors:
Muller, M
Voss, M
Heise, C
Schulz, T
Bunger, J
Hallier, E
Citation: M. Muller et al., High-performance liquid chromatography/fluorescence detection of S-methylglutathione formed by glutathione-S-transferase T1 in vitro, ARCH TOXIC, 74(12), 2001, pp. 760-767
Authors:
Heise, C
Citation: C. Heise, Fuss over Fuss (High prices for Adam Fuss's photographic works), ARTNEWS, 100(10), 2001, pp. 106-106
Authors:
Khuri, FR
Nemunaitis, J
Ganly, I
Arseneau, J
Tannock, IF
Romel, L
Gore, M
Ironside, J
MacDougall, RH
Heise, C
Randlev, B
Gillenwater, AM
Bruso, P
Kaye, SB
Hong, WK
Kirn, DH
Citation: Fr. Khuri et al., A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer, NAT MED, 6(8), 2000, pp. 879-885
Authors:
Heise, C
Hermiston, T
Johnson, L
Brooks, G
Sampson-Johannes, A
Williams, A
Hawkins, L
Kirn, D
Citation: C. Heise et al., An adenovirus E1A mutant that demonstrates potent and selective systemic antitumoral efficacy (vol 6, pg 1134, 2000), NAT MED, 6(12), 2000, pp. 1412-1412
Authors:
Heise, C
Hermiston, T
Johnson, L
Brooks, G
Sampson-Johannes, A
Williams, A
Hawkins, L
Kirn, D
Citation: C. Heise et al., An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy, NAT MED, 6(10), 2000, pp. 1134-1139
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
VonHoff, DD
Kaye, SB
Citation: I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intramorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 6(9), 2000, pp. 3797-3797
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
Von Hoff, DD
Kaye, SB
Citation: I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer, CLIN CANC R, 6(3), 2000, pp. 798-806
Authors:
Heise, C
Lemmon, M
Kirn, D
Citation: C. Heise et al., Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: Dependence on sequencing but not p53 functional status or route of administration, CLIN CANC R, 6(12), 2000, pp. 4908-4914
Authors:
Heise, C
Ganly, I
Kim, YT
Sampson-Johannes, A
Brown, R
Kirn, D
Citation: C. Heise et al., Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status, GENE THER, 7(22), 2000, pp. 1925-1929
Authors:
Heise, C
Kirn, DH
Citation: C. Heise et Dh. Kirn, Replication-selective adenoviruses as oncolytic agents, J CLIN INV, 105(7), 2000, pp. 847-851
Authors:
Hermiston, T
Heise, C
Kirn, DH
Citation: T. Hermiston et al., The discovery and development of selectively replicating adenoviruses as anticancer agents, TUMOR TARG, 4(4), 1999, pp. 218-224
Authors:
Weber, SM
Shi, FS
Heise, C
Warner, T
Mahvi, DM
Citation: Sm. Weber et al., Interleukin-12 gene transfer results in CD8-dependent regression of murineCT26 liver tumors, ANN SURG O, 6(2), 1999, pp. 186-194
Risultati:
1-14
|